Investors looking for reliable income this May should consider two standout dividend stocks: AbbVie (ABBV) and Realty Income (O). AbbVie recently declared a quarterly cash dividend of $1.73 per share, marking its 54th consecutive year of dividend increases, a testament to its robust business model and successful navigation of patent challenges. Despite losing exclusivity on its top-selling drug Humira, AbbVie has maintained growth through strategic acquisitions and a promising pipeline, with a forward yield above 3.3%.
On the other hand, Realty Income, known as “The Monthly Dividend Company,” offers a compelling monthly dividend with a forward yield exceeding 5%. The REIT has paid dividends for 670 consecutive quarters, benefiting from a diversified portfolio of over 15,500 properties that generate steady cash flow. Its strong occupancy rate of 98.9% and focus on resilient retail tenants position it well for continued dividend reliability.
For income-focused investors, both AbbVie and Realty Income present attractive options, reinforcing the idea that selling in May may not be the best strategy for those prioritizing dividends.
Source: fool.com